FinalDose: Funding, Investors & Team (Oct 2026)
FinalDose develops programmable DNA therapeutics that target diseases at the level of their underlying genetic code. The company focuses on a DNA drug platform that uses engineered fusion proteins to scan cellular genomes for predefined diseased DNA sequences. When the therapeutic recognizes its programmed target, it undergoes a structural change that activates a cellular kill switch to eliminate the diseased cell while sparing neighboring healthy tissue. This approach aims to address disease drivers that are considered undruggable by conventional protein-targeting methods. FinalDose initially applies its platform to cancers driven by complex mutations, using established human genetics knowledge to guide target selection and reduce research and validation cycles.
FinalDose has raised $500k across 1 funding round on record, the most recent a Pre-Seed of $500k announced in Jun 2026.
That round is below the $6.0M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
FinalDose Company Profile and Key Stats
Latest funding round on record: Jun 2026.
FinalDose Funding Rounds
FinalDose Founders and Leadership Team
No contact details are on record for this team yet.
FinalDose Funding Compared to Other Artificial Intelligence Startups
FinalDose's latest round of $500k is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like FinalDose in Artificial Intelligence and Altrincham
Companies Similar to FinalDose
Basecamp Research is a market leader in mapping biodiversity for AI-based design of biological systems. We…
FintechOS is a leading provider of fintech solutions, aiming to democratize fintech innovation for all…
The largest GPU Cloud purpose built for AI. Instantly deploy thousands of NVIDIA H100s and A100s on demand,…
Stability AI is developing open AI resources that enable us to maximize our capabilities. We create and…
Callosum provides data analytics, artificial intelligence, and digital engineering services for data…
Medly AI is an advanced tutor that is able to support students in multiple languages through the use of…
Mindgard is an AI security company that assists businesses in safeguarding their AI models against cyber…
Edgify is a developer of a predictive personalization technology used to analyze a user's photos on their…
The AI agents provided by Finster AI possess the ability to comprehend, evaluate, and incorporate various…
Malted AI is a company that designs a low-code platform that allows businesses to create and launch…
OLIX designs and manufactures optical processors that use light-based circuits to accelerate artificial…
Qureight is a company specializing in imaging analytics, with a goal of enhancing its analytical platform to…
FinalDose Funding FAQs
What does FinalDose do?
FinalDose develops programmable DNA therapeutics that target diseases at the level of their underlying genetic code. The company focuses on a DNA drug platform that uses engineered fusion proteins to scan cellular genomes for predefined diseased DNA sequences. When the therapeutic recognizes its programmed target, it undergoes a structural change that activates a cellular kill switch to eliminate the diseased cell while sparing neighboring healthy tissue. This approach aims to address disease drivers that are considered undruggable by conventional protein-targeting methods. FinalDose initially applies its platform to cancers driven by complex mutations, using established human genetics knowledge to guide target selection and reduce research and validation cycles.
How much funding has FinalDose raised?
FinalDose has raised $500k across 1 round on record. The most recent is a Pre-Seed of $500k announced in Jun 2026.
When did FinalDose last raise funding?
FinalDose's most recent funding round on record is a Pre-Seed of $500k, announced in Jun 2026.
Who founded FinalDose?
FundedIQ lists Steven Lin (Founder) at FinalDose.
Where is FinalDose headquartered?
FinalDose is based in Altrincham, Cheshire, United Kingdom.
How many employees does FinalDose have?
FinalDose is in the 1-10 employee band.
How does FinalDose's funding compare to other Artificial Intelligence startups?
FinalDose's latest round of $500k is below the $6.0M median round size for Artificial Intelligence companies on FundedIQ across 7,239 tracked companies over the last two years.
About FundedIQ's FinalDose Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for FinalDose is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.